Del Labs
This article was originally published in The Tan Sheet
Executive Summary
Net sales jumped 14.6% to $87.9 mil. in Q2, primarily driven by "continued growth" in Orajel line, cosmetics segment, firm says. Net income for quarter was $3.3 mil., up 74% compared to earnings of $1.9 mil. last year. Six-month sales totaled $160.7 mil., rising 11.4% over prior-year period. Orajel Multi Action Cold Sore Medicine shipped in June, along with new products in Dermarest Psoriasis line; TV ads slated to break in September (1"The Tan Sheet" May 7, p. 5)